Functional effects of GDNF in normal rat striatum: Presynaptic studies using in vivo electrochemistry and microdialysis

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1181-1190

  Hebert, Meleik A ^a   Van Horne, Craig G ^a,b   Hoffer, Barry J ^a   Gerhardt, Greg A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; ELECTROCHEMISTRY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PRESYNAPTIC TERMINALS; RATS; RATS, INBRED F344; SUBSTANTIA NIGRA;

EID: 0030438456     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. BECK, K. D., IRWIN, I., VALVERDE, J., BRENNAN, T. J., LANGSTON, J. W. AND HEFTI, F.: GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16: 665-673, 1996.
2. BECK, K., KNUSEL, B. AND HEFTI, F.: The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic DAergic neurons developing in culture. Neuroscience 52: 855-866, 1993.
3. BECK, K. D., VALVERDE, J., ALEXI, T., POULSEN, K., MOFFAT, B., VANDLEN, R. A., ROSENTHAL, A. AND HEFTI, F.: Mesencephalic DAergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature (Lond.) 373: 339-341, 1995.
4. BENINGER, R. J., COOPER, T. A. AND MAZURSKI, E. K.: Automating the measurement of locomotor activity. Neurobehav. Tox. Ter. 7: 79-85, 1985.
5. BJORKLUND, A. AND STENEVI, U.: Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177: 555-560, 1979.
6. BOWENKAMP, K E., HOFFMAN, A. F., GERHARDT, G. A., HENRY, M. A., BIDDLE, P. T., HOFFER, B. J. AND GRANHOLM, A.-C.: Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355: 479-489, 1995.
7. CASS, W. A., GERHARDT, G. A., GILLESPIE, K., CURELLA, P., MAYFIELD, R. D. AND ZAHNISER, N. R.: Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. J. Neurochem. 61: 273-283, 1993a.
8. CASS, W. A., GERHARDT, G. A., MAYFIELD, R. D., CURELLA, P. AND ZAHNISER, N. R.: Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J. Neurochem. 59: 259-266, 1992.
9. CASS, W. A., ZAHNISER, N. R., FLACH, K. A. AND GERHARDT, G. A.: Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: Role of metabolism and effects of locally applied uptake inhibitors. J. Neurochem. 61: 2269-2278, 1993b.
10. CHURCH, W. H. AND JUSTICE, J. B., JR.: Rapid sampling and determination of extracellular dopamine in vivo. Anal. Chem. 59: 712-716, 1987.
11. FRIEDEMANN, M. N. AND GERHARDT, G. A.: Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol. Aging 13: 325-332, 1992.
12. GERHARDT, G. A.: Rapid chronocoulometric measurements of norepinephrine overflow and clearance in CNS tissues. In Neuromethods, 27: Voltammetric Methods in Brain Systems, ed. by A. Boulton, G. Baker and R. N. Adams, pp. 117-151, Humana Press, Clifton, NJ, 1995.
13. GERHARDT, G. A., GRATTON, A. AND ROSE, G. M.: In vivo electrochemical studies of the effects of cocaine on DA nerve terminals on rat neostriatum. Physiol. Bohemoslov. 37: 249-257, 1988.
14. GERHARDT, G., OKE, A., MOGHADDAM, B. AND ADAMS, R. N.: Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290: 390-395, 1984.
15. GERHARDT, G. A. AND PALMER, M. R.: Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J. Neurosci. Meth. 22: 147-159, 1987.
16. GERHARDT, G. A., PALMER, M. R. AND GRANHOLM, A.-C.: Age-induced changes in single locus coeruleus brain transplants grown in oculo: An in vivo electrochemical study. Neurobiol. Aging, 12: 487-494, 1991.
17. GERHARDT, G. A., ROSE, G. M. AND HOFFER, B. J.: Release of monoamines from striatum of rat and mouse by local application of potassium: Evaluation of a new in vivo electrochemical technique. J. Neurochem. 46: 842-850, 1986.
18. GIROS, B., JABER, M., JONES, S. R., WIGHTMAN, R. M. AND CARON, M. G.: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (Lond.) 379: 606-612, 1996.
19. GRATTON, A., HOFFER, B. J. AND GERHARDT, G. A.: In vivo electrochemical studies of monoamine release in the medial prefrontal cortex of the rat. Neuroscience 29: 57-64, 1989.
20. HAGG, T. AND VARON, S.: Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra DAergic neurons. Proc. Natl. Acad. Sci. U.S.A. 90: 6315-6319, 1993.
21. HALL, M. E., HOFFER, B. J. AND GERHARDT, G. A.: Rapid and sensitive determination of catecholamines in small tissue samples by high pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC-GC 7: 258-265, 1989.
22. HOFFER, B. J., HOFFMAN, A., BOWENKAMP, K., HUETTL, P., HUDSON, J., MARTIN, D., LIN, L.-F. H. AND GERHARDT, G. A.: Glial cell line derived neurotrophic factor reverses toxin-induced injury to midbrain DAergic neurons in vivo. Neurosci. Lett. 182(1): 107-111, 1994.
23. HORNYKIEWICZ, O.: Parkinson's disease and the adaptive capacity of the nigrostriatal DA system: Possible neurochemical mechanisms. Adv. Neurol. 60: 140-147, 1993.
24. HORNYKIEWICZ, O. AND KISH, S. J.: Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45: 19-34, 1987.
25. HUDSON, J., GRANHOLM, A.-C., GERHARDT, G. A., HENRY, M. A., HOFFMAN, A., BIDDLE, P., LEELA, N. S., MACKERLOVA, L., LILE, J. D., COLLINS, F. AND HOFFER, B. J.: Glial cell line-derived neurotrophic factor augments midbrain DAergic circuits in vivo. Brain Res. Bull. 36(5): 425-432, 1995.
26. HYMAN, C., JUHASZ, M., JACKSON, C., WEIGHT, P., IP, N. Y. AND LINDSAY, R. M.: Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured DAergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14(1): 335-347, 1994.
27. HYNES, M. A., POULSEN, K., ARMANINI, M., BIRKENMEIER, L., PHILLIPS, H. AND ROSENTHAL, A.: Neurotrophin-4/5 is a survival factor for embryonic midbrain DAergic neurons in enriched cultures. J. Neurosci. Res. 37: 144-154, 1994.
28. KEARNS, C. M. AND GASH, D. M.: GDNF protects nigral DA neurons against 6-hydroxy DA in vivo. Brain Res. 672: 104-111, 1995.
29. LIN, L.-F. H., DOHERTY, D. H., LILE, J. D., BEKTESH, S. AND COLLINS, F.: GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132, 1993.
30. LIN, L.-F. H., ZHANG, T. J., COLLINS, F. AND ARMES, L. G.: Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63(2): 758-768, 1994.
31. LINDSAY, R. M.: Neuron saving schemes. Nature (Lond.) 373: 290, 1995.
32. LINDSAY, R. M., ALTAR, C. A., CEDARBAUM, J. M., HYMAN, C. AND WIEGAND, S. J.: The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp. Neurol. 124: 103-118, 1993.
33. LUTHMAN, J., FRIEDEMANN, M. N., HOFFER, B. J. AND GERHARDT, G. A.: In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine-treated rat striatum. Exp. Neurol. 122: 273-282, 1993.
34. MAGAL, E., BURNHAM, P., VARON, S. AND LOUIS, J.-C.: Convergent regulation by ciliary neurotrophic factor and DA of tyrosine hydroxylase expression in cultures of rat substantia nigra. Neuroscience 52: 867-881, 1993.
35. MENACHERRY, S., HUBERT, W. AND JUSTICE, J. B., JR.: In vivo calibration of microdialysis probes for exogenous compounds. Anal. Chem. 64: 577-583, 1992.
36. MONTGOMERY, E. B., JR., NUESSEN, J. AND GORMAN, A. B.: Reaction time and movement velocity abnormalities in Parkinson's disease under different task conditions, Neurology 41: 1476-1481, 1991.
37. NIKKAH, G., ODEIN, P., SMITS, A., TINGSTROM, A., OTHBERG, A., BRUNDIN, P., FUNA, K. AND LINDVALL, O.: Platelet-derived growth factor promotes survival of rat and human mesencephalic DAergic neurons in culture. Exp. Brain. Res. 92: 516-523, 1993.
38. OLSON, L.: Neurotrophins in neurodegenerative disease: Theoretical issues and clinical trials. Neurochem. Intl. 25(1): 1-3, 1994.
39. OLSON, L., BACKMAN, L., EBENDAL, T., ERIKSDOTTER-JONHAGEN, M., HOFFER, B., HUMPEL, C., FREEDMAN, R., GIACOBINI, M., MEYERSON, B. AND NORDBERG, A.: Role of growth factors in degeneration and regeneration in the CNS: Clinical experiences with NGF in Parkinson's and Alzheimer's diseases. J. Neurol. 242(1 suppl. 1): S12-15, 1994.
40. PAKINOS, S. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, Sydney, Australia, 1986.
41. PERLOW, M., FREED, W., HOFFER, B., SEIGER, A., OLSON, L. AND WYATT, R.: Brain grafts reduce motor abnormalities produced by CNS damage. Science (Wash. DC) 204: 643-647, 1979.
42. RINNE, U. K. AND SONNINEN, V.: A double blind study of 1-dopa treatment in Parkinson's disease. Eur. Neurol. 1: 180-191, 1968.
43. ROSE, G., GERHARDT, G., STROMBERG, I., OLSON, L. AND HOFFER, B.: Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: An in vivo electrochemical study. Brain Res., 341: 92-100, 1985.
44. SAUER, H., ROSENBLAD, C. AND BJORKLAND, A.: Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. U.S.A. 92(19): 8935-8939, 1995.
45. SPINA, M., SQUINTO, S., MILLER, J., LINDSAY, R. AND HYMAN, C.: Brain-derived neurotrophic factor protects DA neurons against 6-hydroxyDA and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J. Neurochem. 59: 99-106, 1992.
46. STROMBERG, I., BJORKLUND, L., JOHANSSON, M., TOMAC, A., COLLINS, F., OLSON, L., HOFFER, B. AND HUMPEL, C.: Glial cell line-derived neurotrophic factor (GDNF) is expressed in the developing but not adult atriatum and stimulates developing DA neurons in vivo. Exp. Neurol. 124: 401-412, 1993.
47. STROMBERG, I., VAN HORNE, C., BYGDEMAN, M., WEINER, N., AND GERHARDT, G. A.: Function of intraventricular human mesencephalic xenografts in immunosuppressed rats: An electrophysiological and neurochemical analysis. Exp. Neurol. 112: 140-152, 1991.
48. SWANSON, L. W.: The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9: 321-353, 1982.
49. SZOSTAK, C., JAKUBOVIC, A., PHILLIPS, A. G. AND FIBIGER, H. C.: Neurochemical correlates of conditioned circling within localized regions of the striatum. Exp. Brain Res. 75: 430-440, 1989.
50. TOMAC, A., LINDQUIST, E., LIN, L.-F. H., ORGEN, S. O., YOUNG, D., HOFFER, B. J. AND OLSON, L.: Protection and repair of the nigrostriatal DAergic system by GDNF in vivo. Nature (Lond.) 373: 335-339, 1995.
51. VAN HORNE, C., HOFFER, B. J., STROMBERG, I. AND GERHARDT, G. A.: Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J. Pharmacol. Exp. Ther. 263: 1285-1292, 1992.